JPRN-UMIN000020019尚未招募未知
Efficacy and safety of paritaprevir and ombitasvir in patients with chronic hepatitis C - Efficacy and safety of paritaprevir and ombitasvir
Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology0 个研究点目标入组 2,000 人开始时间: 2015年12月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Contraindication to paritaprevir or ombitasvir, ritonavir 2)Contraindication to paritaprevir and ombitasvir
研究者
相似试验
未知
不适用
The efficacy of paritaprevir and ombitasvir with a booster dose of ritonavir in genotype 1 HCV patients with hemodialysishemodialysis patients chronically infected with genotype 1 hepatitis C virusJPRN-UMIN000022563Mitsui Memorial Hospital30
招募中
不适用
Efficacy and safety of ombitasvir/paritaprevir/ritonavir, ledipasvir/sofosbuvir, elbasvir /grazoprevir, glecaprevir/pibrentasvir after curative treatment of HCV-Related HCC - Prospective multicenter-cooperative cohort studyHCV-related hepatocellular carcinomaJPRN-UMIN000025085Juntendo University Hospital80
已完成
不适用
Efficacy and safety of Ombitasvir/Paritaprevir/Ritonavir in chronic hepatitis C patientsChronic hepatitis CJPRN-UMIN000021123shonan kamakura general hospital100
已完成
不适用
Efficacy and Safety of Ombitasvir plus Paritaprevir/r combination regimen for Hepatitis C infected patients with immune disordersPatients with genotype 1 HCV infection who have immune disorderJPRN-UMIN000020302Hokkaido University50
招募中
不适用
Evaluation of the efficacy of ombitasvir and paritaprevir with ritonavir for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000021276Toranomon Hospital100